Skip to main content
Figure 11 | Breast Cancer Research

Figure 11

From: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

Figure 11

Clinical association of JMJD6 with TGF-β2. Pearson correlation of clinical expression of JMJD6 with TGF-β2 suggests a negative correlation with TGF-β2 (P = 9.13 × 10-8). Scatterplot shows the normalized JMJD6 expression of each patient sample with the corresponding normalized TGF-β2 expression in the clinical dataset of 2,034 breast cancer patients.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us